Cerebral Tissue Oxygenation in Highlanders/Lowlanders

NCT03172429 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79

Last updated 2019-08-16

No results posted yet for this study

Summary

The purpose of the current study is to evaluate the cerebral tissue oxygenation of Kyrgyz highlanders with high altitude pulmonary hypertension (HAPH) by performing a longitudinal cohort study. To this end, the investigators will invite the same highlanders who participated in the study in 2012 to undergo follow-up examinations in 2017, in order to allow comparisons of current results with baseline data from 2012.

Conditions

  • High Altitude Pulmonary Hypertension

Sponsors & Collaborators

  • National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov

    collaborator OTHER_GOV
  • University of Zurich

    lead OTHER

Principal Investigators

  • Talant M Sooronbaev, MD · NCCIM

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-24
Primary Completion
2017-08-16
Completion
2017-08-16

Countries

  • Kyrgyzstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03172429 on ClinicalTrials.gov